IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Catalys Pacific, LLC

Q4 2023 Holdings

Filed 2024-02-14 | 3 holdings | $106.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Mineralys Therapeutics, Inc.(MLYS)COM603170101$79.1M9,194,57974.1%
HilleVax, Inc.COM43157M102$21.0M1,308,97419.7%
Phathom Pharmaceuticals, Inc.(PHAT)COM71722W107$6.6M721,9626.2%